Innovative Clinical Research Solutions for Pharma and Biotech
Innovative Clinical Research Solutions for Pharma and BiotechInnovative Clinical Research Solutions for Pharma and BiotechInnovative Clinical Research Solutions for Pharma and BiotechInnovative Clinical Research Solutions for Pharma and Biotech
About emas pharma Experience
Oncology
Orphan & Rare Diseases
Orphan & Rare Diseases
Stem Cell Transplantation
Immunology / CAR-T
Glioblastoma
Pediatric Neuroblastoma
Ewings Sarcoma
Epidermal Growth Factor
Advanced Solid Tumours
Melanoma
Head & Neck Cancer
Brain Cancer
Bladder Cancer
Cancer Cachexia
Breast Cancer
Myelodysplastic Syndrome
Triple Negative Breast Cancer
Cutaneous T Cell Lymphoma
Plasmacytoid T-Cell Lymphoma
Non Small Cell L
Stem Cell Transplantation
Immunology / CAR-T
Glioblastoma
Pediatric Neuroblastoma
Ewings Sarcoma
Epidermal Growth Factor
Advanced Solid Tumours
Melanoma
Head & Neck Cancer
Brain Cancer
Bladder Cancer
Cancer Cachexia
Breast Cancer
Myelodysplastic Syndrome
Triple Negative Breast Cancer
Cutaneous T Cell Lymphoma
Plasmacytoid T-Cell Lymphoma
Non Small Cell Lung Cancer
Non-Hodgkins Lymphoma
Lymphoma
Multiple Myeloma
Pancreatic cancer
Gastroenteric Cancer
Acute Myeloid Leukaemia
Small Cell Lung Cancer
Prostate Cancer
Ovarian Cancer
Orphan & Rare Diseases
Orphan & Rare Diseases
Orphan & Rare Diseases
Hunter Syndrome (MPS II)
Glioblastoma
McArdle Disease
Cystic Fibrosis
Primary Mitochondrial Myopathy
Xerostomia
Tuberous Sclerosis Complex
Pediatric Neuroblastoma
Degenerative Inflammatory Disease
Duchenne Muscular Dystrophy
Tuberous Sclerosis Complex
Hypogonadism
Retinitis Pigmentosa
Paroxysmal Nocturnal Hemoglobinuria
Achromatopsia
Hypocalcemia Type 1
Huntington’s Disease
Immunology
Orphan & Rare Diseases
Immunology
Immunotherapy
Crohn's Disease
Allergic Rhinitis
Degenerative Inflammatory Disease
Multiple Sclerosis
Asthma
Paroxysmal Nocturnal Hemoglobinuria
Neurology
Gynaecology & Sexual Health
Gynaecology & Sexual Health
Hunter Syndrome
Narcolepsy
Glioblastoma
Epilepsy
Multiple Sclerosis
Mild Cognitive Impairment
Alzheimer's Disease
Parkinson's Disease
Depression
Duchenne's Muscular Dystrophy
Tuberous Sclerosis Complex
Gynaecology & Sexual Health
Gynaecology & Sexual Health
Gynaecology & Sexual Health
Ovarian Cancer
Premature Ejaculation
Erectile Dysfunction
Castrate Resistant Prostate Cancer
Hypogonadism
Infectious Disease
Gynaecology & Sexual Health
Infectious Disease
Septicaemia
Hepatitis C
HIV
Invasive Candidiasis
Malaria
COVID
Long COVID
Vaccination
Chronic Cough
Influenza A
Pneumonia
Gastroenterology
Other Indications
Other Indications
Gastroesophageal Reflux Disease
Inflammatory Bowel Disease
Dyspepsia
Acute Pancreatitis
Liver Cirrhosis
Diabetes Mellitus
Xerostomia
Chronic Cough
Dysphagia
Other Indications
Other Indications
Other Indications
Asthma
Cystic Fibrosis
Hypertriglyceridemia
Type II Diabetes Mellitus
Muscle Regeneration
Primary Mitochondrial Myopathy
Hypocalcaemia Type 1
Complement 3 Glomerulopathy
Ophthalmology
Other Indications
Ophthalmology
Dry Eye
RPGR Genetic Therapy
OPTRPE65 genetic therapy
Retinitis Pigmentosa
Night blindness
Achromatopsia
EMAS Pharma Ltd is a UK company registered (Company No. 03187186)
Suite 209, Spirella Building, Bridge Road, Letchworth Garden City, Hertfordshire, SG6 4ET
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.